CA2193344A1 - Immunological determination method - Google Patents

Immunological determination method

Info

Publication number
CA2193344A1
CA2193344A1 CA002193344A CA2193344A CA2193344A1 CA 2193344 A1 CA2193344 A1 CA 2193344A1 CA 002193344 A CA002193344 A CA 002193344A CA 2193344 A CA2193344 A CA 2193344A CA 2193344 A1 CA2193344 A1 CA 2193344A1
Authority
CA
Canada
Prior art keywords
specific binding
determination method
binding component
immunological determination
analyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002193344A
Other languages
French (fr)
Other versions
CA2193344C (en
Inventor
Hans-Erwin Pauly
Hanna Peiseler-Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Products GmbH
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of CA2193344A1 publication Critical patent/CA2193344A1/en
Application granted granted Critical
Publication of CA2193344C publication Critical patent/CA2193344C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5768—Hepatitis A
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms

Abstract

The present invention relates to a competitive immuno chemical determination method in which the concentration of the analyte is determined in a 1-step process and the analyte in this case competes with a first and a second specific binding component for binding to a third specific binding component, the first specific binding component being bound to a water-insoluble support and the second specific binding component being provided with a signal-generating label.
CA002193344A 1995-12-27 1996-12-18 Immunological determination method Expired - Fee Related CA2193344C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19548375A DE19548375A1 (en) 1995-12-27 1995-12-27 Immunological method of determination
DE19548375.8 1995-12-27

Publications (2)

Publication Number Publication Date
CA2193344A1 true CA2193344A1 (en) 1997-06-28
CA2193344C CA2193344C (en) 2005-12-13

Family

ID=7781175

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002193344A Expired - Fee Related CA2193344C (en) 1995-12-27 1996-12-18 Immunological determination method

Country Status (8)

Country Link
EP (1) EP0781998B1 (en)
JP (1) JPH09189698A (en)
KR (1) KR970048453A (en)
AT (1) ATE256291T1 (en)
AU (1) AU7549796A (en)
CA (1) CA2193344C (en)
DE (2) DE19548375A1 (en)
ES (1) ES2211929T3 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7867781B2 (en) 2000-12-22 2011-01-11 Siemens Healthcare Diagnostics Products Gmbh Detection methods
US8399209B2 (en) 2003-12-01 2013-03-19 Siemens Healthcare Diagnostics Products Gmbh Homogeneous detection method

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922558A (en) * 1997-09-12 1999-07-13 Lumigen, Inc. Methods and compositions for generating chemiluminescence with a peroxidase
US7432046B2 (en) * 2005-11-02 2008-10-07 Abbott Laboratories Methods for the determination of antibody IgG avidity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1172561A (en) * 1981-01-28 1984-08-14 Richard H. Decker Igm detection method
DE3834766A1 (en) * 1988-10-12 1990-04-26 Boehringer Mannheim Gmbh METHOD FOR DETERMINING A SPECIFICALLY BINDABLE SUBSTANCE

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7867781B2 (en) 2000-12-22 2011-01-11 Siemens Healthcare Diagnostics Products Gmbh Detection methods
US8399209B2 (en) 2003-12-01 2013-03-19 Siemens Healthcare Diagnostics Products Gmbh Homogeneous detection method
US8628933B2 (en) 2003-12-01 2014-01-14 Siemens Healthcare Diagnostics Products Gmbh Homogeneous detection method

Also Published As

Publication number Publication date
ATE256291T1 (en) 2003-12-15
EP0781998A3 (en) 1998-08-12
JPH09189698A (en) 1997-07-22
KR970048453A (en) 1997-07-29
CA2193344C (en) 2005-12-13
AU7549796A (en) 1997-07-03
DE19548375A1 (en) 1997-07-03
ES2211929T3 (en) 2004-07-16
EP0781998B1 (en) 2003-12-10
DE59610859D1 (en) 2004-01-22
EP0781998A2 (en) 1997-07-02

Similar Documents

Publication Publication Date Title
CA2215042A1 (en) Assay reagents and devices
AU5665696A (en) Novel methods for the assay of troponin i and t and complexe s of troponin i and t and selection of antibodies for use in immunoassays
CA2249638A1 (en) Kit and method for fluorescence based detection assay
AU642403B2 (en) Method for the use and synthesis of peptides
CA2224674A1 (en) Immunoassay and kit with two reagents that are cross-linked if they adhere to an analyte
GB2330655A (en) Method and system for performing a binding assay
ZA96357B (en) Quantitative detection of analytes on immunochromatographic strips
AU5799898A (en) Method for improving the recovery of troponin i and t
CA2198958A1 (en) Method for amplification of the response signal in a sandwich immunoassay
AU3927597A (en) Covered sample well for use in nucleic acid assays and immunoassays
EP0842948A4 (en) ANTIFas LIGAND ANTIBODIES AND ASSAY METHOD BY USING THE SAME
AU4213396A (en) Kit for immunologically assaying biological substance and assay process
EP1255209A3 (en) Apparatus and method for automated protein design
CA2188093A1 (en) Process for purifying factor vii and activated factor vii
EP0753743A3 (en) Vitamin D assay
EP0864647A4 (en) Fructosyl amino acid oxidase, process for producing the same, and method of assaying amadori compounds using the enzyme
AU4553296A (en) Method and reagent for the specific determination of LDL in serum samples
EP1742056A3 (en) Determination of a specific immunglobulin using multiple antigens
CA2097545A1 (en) Process for the immunochemical determination of an analyte
AU8917291A (en) Method for quantitatively assaying the presence fo diarrhetic shellfish poisoning toxins in marine samples.
CA2290582A1 (en) Rapid evaluation of the ratio of biological molecules
CA2193344A1 (en) Immunological determination method
CA2219947A1 (en) Monoclonal antibody reactive to human cetp and assay method for human cetp
CA2167321A1 (en) Reagents and methods for the detection and quantification of testosterone in fluid samples
EP0419081A3 (en) Method for protein binding enzyme complementation assays

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20131218